NSC LUNG (First-Line)

• CZOL446E US75, " A Prospective, Multicenter, Randomized , Phase II Study to Evaluate the Effects of Zometa® in Combination with Taxotere®/Carboplatin in Patients with Stage IIIB/IV Unresectable Non-Small Cell Lung Cancer."
  Stage IIIB or IV NSCLC
• No Bone or Brain mets
• No prior bisphosphonate
• We can put up to 10 patients on this study we have 1

• 145-03D , "Open-Label, Multicenter Prospective Trial Evaluating the Reduction of Treatment Breaks with Amifostine (Ethyol®) in Patients with Measurable, Unresectable Non-Small Cell lung Cancer."
  • Unresectable stage IIIA or IIIB
  • No distant mets. including brain
  • No prior chemo or radiation
  • We need to put 5 patients on this study we have 4.

« back to Clinical Trials list